Moderna is trading 4.2% down today at $54.65 amid broader biotech weakness and risk-off sentiment.
- The decline extends a multi-session slide for the stock, which has been trending sharply lower since mid-July.
- There is no fresh company-specific news or earnings today; the move appears driven by sector-wide pressure on higher-risk growth names.
- Broader market factors, including recent tech volatility and tariff uncertainty, continue to weigh on the biotech space.